Stay updated on UBX0101 Safety & Efficacy in Knee Osteoarthritis Clinical Trial
Sign up to get notified when there's something new on the UBX0101 Safety & Efficacy in Knee Osteoarthritis Clinical Trial page.

Latest updates to the UBX0101 Safety & Efficacy in Knee Osteoarthritis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now includes detailed results from a clinical study comparing the WOMAC-A and WOMAC-C scores in patients receiving UBX0101 versus placebo, highlighting significant changes in pain and physical disability over a 12-week period. Additionally, there is a note about missing data for some subjects in the analysis.SummaryDifference16%
- Check28 days agoChange DetectedThe recent changes removed detailed information regarding the WOMAC-A and WOMAC-C scores from a clinical study comparing UBX0101 to placebo, including participant numbers and score changes over time.SummaryDifference13%
- Check35 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check42 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check56 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
- Check63 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
Stay in the know with updates to UBX0101 Safety & Efficacy in Knee Osteoarthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UBX0101 Safety & Efficacy in Knee Osteoarthritis Clinical Trial page.